228760 — Genomictree Cashflow Statement
0.000.00%
Last trade - 00:00- KR₩350bn
- KR₩256bn
- KR₩2bn
Annual cashflow statement for Genomictree, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | Annual Audited Accounts | Annual Audited Accounts | ARS | Annual Audited Accounts | Annual Audited Accounts |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -11,723 | -11,425 | -6,237 | -9,007 | -10,390 |
| Depreciation | |||||
| Amortisation | |||||
| Deferred Taxes | |||||
| Non-Cash Items | 577 | 6,263 | 12,108 | -3,127 | -2,112 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | 51.1 | -3,491 | -3,301 | 75.7 | -2,329 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Prepaid Expenses | |||||
| Change in Other Assets | |||||
| Change in Accounts Payable | |||||
| Change in Accrued Expenses | |||||
| Change in Taxes Payable | |||||
| Change in Other Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | -10,188 | -7,631 | 4,286 | -10,881 | -13,633 |
| Capital Expenditures | -2,782 | -11,828 | -1,824 | -288 | -2,552 |
| Purchase of Fixed Assets | |||||
| Purchase / Acquisition of Intangibles | |||||
| Other Investing Cash Flow Items | 17,037 | -37,244 | 15,893 | 8,407 | -8,936 |
| Sale of Fixed Assets | |||||
| Sale/Maturity of Investment | |||||
| Change in Net Investments | |||||
| Purchase of Investments | |||||
| Sale of Intangible Assets | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | 14,255 | -49,072 | 14,069 | 8,119 | -11,488 |
| Financing Cash Flow Items | -0.312 | -2,000 | -2.15 | -20,439 | -5.17 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 12,977 | 62,869 | -19,525 | -20,497 | 6,022 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 13,741 | 9,820 | 1,110 | -22,856 | -18,998 |